R01CA279452 (TWEARDY, DAVID JOHN)Dec 19, 2023 - Nov 30, 2028 NIH Targeting non-small cell lung cancer cells and the adverse tumor microenvironment with a small-molecule STAT3 inhibitor Role: Principal Investigator |
|
R01CA269516 (TWEARDY, DAVID JOHN)Aug 3, 2022 - Jul 31, 2027 NIH Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor Role: Principal Investigator |
|
R42DK104494 (TWEARDY, DAVID JOHN)Apr 8, 2016 - Mar 31, 2021 NIH Oral Small Molecule STAT3 Inhibitor to Treat Cachexia in Chronic Kidney Disease Role: Principal Investigator |
|
R21CA191556 (TWEARDY, DAVID JOHN)Dec 1, 2014 - Nov 30, 2017 NIH Targeting Stat1 and Stat3 to Reverse Radioresistance in Head and Neck Cancer Role: Principal Investigator |
|
R41CA153658 (TWEARDY, DAVID JOHN)Sep 26, 2012 - Aug 31, 2014 NIH Chemical probes that target Stat3 to treat cancer Role: Principal Investigator |
|
R21CA149783 (TWEARDY, DAVID JOHN)Jul 1, 2010 - Jun 30, 2012 NIH Stat3 Probes that Target Breast Cancer Stem Cells Role: Principal Investigator |
|
R01HL076169 (TWEARDY, DAVID JOHN)Feb 1, 2004 - Jan 31, 2009 NIH REVERSAL OF HYPOVOLEMIC CIRCULATORY COLLAPSE BY IL-6 Role: Principal Investigator |
|
T32AI055413 (GIORDANO, THOMAS P)Aug 1, 2003 - Jun 30, 2025 NIH Research Training in Infection and Immunity Role: Co-Principal Investigator |
|
R01CA086430 (TWEARDY, DAVID JOHN)Sep 1, 1999 - Jun 30, 2005 NIH STAT3 INTERACTIONS IN CELL GROWTH AND DIFFERENTIATION Role: Principal Investigator |
|
R01CA072261 (TWEARDY, DAVID JOHN)May 1, 1996 - Jun 30, 2008 NIH Mechanisms of G-CSF Receptor Mediated Differentiation Role: Principal Investigator |
|
T32AI007333 (MELLORS, JOHN W)Sep 1, 1988 - Aug 31, 2011 NIH Training in AIDS Molecular Epi/Microbiology &STDs Role: Co-Principal Investigator |
|
K11HL001763 (TWEARDY, DAVID JOHN)Apr 1, 1986 - Mar 31, 1991 NIH SUPPRESSION OF HEMOPOIESIS BY A NOVEL LYMPHOKINE Role: Principal Investigator |